Jon Van Loon

1.3k total citations · 1 hit paper
18 papers, 990 citations indexed

About

Jon Van Loon is a scholar working on Molecular Biology, Pediatrics, Perinatology and Child Health and Animal Science and Zoology. According to data from OpenAlex, Jon Van Loon has authored 18 papers receiving a total of 990 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Pediatrics, Perinatology and Child Health and 3 papers in Animal Science and Zoology. Recurrent topics in Jon Van Loon's work include Pharmacogenetics and Drug Metabolism (3 papers), Acute Lymphoblastic Leukemia research (3 papers) and Pharmacological Effects and Assays (3 papers). Jon Van Loon is often cited by papers focused on Pharmacogenetics and Drug Metabolism (3 papers), Acute Lymphoblastic Leukemia research (3 papers) and Pharmacological Effects and Assays (3 papers). Jon Van Loon collaborates with scholars based in United States, Canada and Netherlands. Jon Van Loon's co-authors include Richard M. Weinshilboum, Lynne Lennard, J S Lilleyman, Gabriel Mwaluko, Joel Dunnette, Christoph Reiter, R. M. Weinshilboum, Augueste Sturk, Christian Burvenich and Hilde Dosogne and has published in prestigious journals such as The Lancet, The Science of The Total Environment and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Jon Van Loon

17 papers receiving 945 citations

Hit Papers

Genetic variation in response to 6-mercaptopurine for chi... 1990 2026 2002 2014 1990 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jon Van Loon United States 12 434 290 259 188 120 18 990
D. Brockmeier Germany 15 268 0.6× 207 0.7× 325 1.3× 261 1.4× 109 0.9× 44 1.2k
Jon A. Van Loon United States 17 587 1.4× 323 1.1× 611 2.4× 425 2.3× 276 2.3× 24 1.6k
Yang Xie China 18 214 0.5× 139 0.5× 592 2.3× 122 0.6× 110 0.9× 45 1.3k
Guoping Zhong China 20 64 0.1× 75 0.3× 429 1.7× 199 1.1× 53 0.4× 92 1.2k
Jiřina Martı́nková Czechia 16 150 0.3× 112 0.4× 113 0.4× 151 0.8× 21 0.2× 45 693
Yu Tang Gao China 16 342 0.8× 164 0.6× 333 1.3× 32 0.2× 183 1.5× 19 1.6k
S M Colman United Kingdom 9 114 0.3× 159 0.5× 263 1.0× 34 0.2× 57 0.5× 11 857
Paul Franck Netherlands 18 62 0.1× 106 0.4× 354 1.4× 117 0.6× 49 0.4× 28 1.4k
J. H. M. Van Tongeren Netherlands 22 76 0.2× 76 0.3× 210 0.8× 79 0.4× 323 2.7× 60 1.3k
B.K. Park United Kingdom 20 152 0.4× 131 0.5× 239 0.9× 557 3.0× 124 1.0× 57 1.3k

Countries citing papers authored by Jon Van Loon

Since Specialization
Citations

This map shows the geographic impact of Jon Van Loon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jon Van Loon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jon Van Loon more than expected).

Fields of papers citing papers by Jon Van Loon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jon Van Loon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jon Van Loon. The network helps show where Jon Van Loon may publish in the future.

Co-authorship network of co-authors of Jon Van Loon

This figure shows the co-authorship network connecting the top 25 collaborators of Jon Van Loon. A scholar is included among the top collaborators of Jon Van Loon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jon Van Loon. Jon Van Loon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Dosogne, Hilde, et al.. (2002). Effect of enrofloxacin treatment on plasma endotoxin during bovine Escherichia coli mastitis. Inflammation Research. 51(4). 201–205. 62 indexed citations
2.
Raftogianis, Rebecca B., T. Wood, Chengtao Her, Jon Van Loon, & R. M. Weinshilboum. (1997). Phenol sulfotransferase (PST) molecular pharmacogenetics. 61(2). 1 indexed citations
3.
Szumlanski, Carol L., et al.. (1994). Purine substrates for human thiopurine methyltransferase. Biochemical Pharmacology. 48(11). 2135–2138. 53 indexed citations
4.
Lennard, Lynne, J S Lilleyman, Jon Van Loon, & Richard M. Weinshilboum. (1990). Genetic variation in response to 6-mercaptopurine for childhood acute lymphoblastic leukaemia. The Lancet. 336(8709). 225–229. 521 indexed citations breakdown →
5.
Loon, Jon Van, et al.. (1990). Assessment of ICP-MS for routine multielement analysis of soil samples in environmental trace element studies. Fresenius Journal of Analytical Chemistry. 336(2). 99–105. 17 indexed citations
6.
Lipsky, James J., et al.. (1985). Cephalosporin-induced hypoprothrombinemia: possible role for thiol methylation of 1-methyltetrazole-5-thiol and 2-methyl-1,3,4-thiadiazole-5-thiol.. Journal of Pharmacology and Experimental Therapeutics. 235(2). 382–388. 28 indexed citations
7.
Campbell, Norman R.C., et al.. (1985). Sulfate and methyldopa metabolism: Metabolite patterns and platelet phenol sulfotransferase activity. Clinical Pharmacology & Therapeutics. 37(3). 308–315. 24 indexed citations
8.
Campbell, Norm R.C., Joel Dunnette, Gabriel Mwaluko, Jon Van Loon, & Richard M. Weinshilboum. (1984). Platelet phenol sulfotransferase and erythrocyte catechol-O-methytransferase activities: Correlation with methyldopa metabolism. Clinical Pharmacology & Therapeutics. 35(1). 55–63. 44 indexed citations
9.
Loon, Jon Van & R. M. Weinshilboum. (1984). Human platelet phenol sulfotransferase (PST): Individual variations in the thermal stability of the 'TS' or 'P' form. 43(3). 1 indexed citations
10.
Loon, Jon Van & Richard M. Weinshilboum. (1984). Human platelet phenol sulfotransferase: Familial variation in thermal stability of the TS form. Biochemical Genetics. 22(11-12). 997–1014. 44 indexed citations
11.
Loon, Jon Van, et al.. (1984). Environmental and biological samples analyzed by inductively coupled plasma emission spectrometry. Water Air & Soil Pollution. 21(1-4). 323–333. 10 indexed citations
12.
Reiter, Clemens, et al.. (1983). Sulphate conjugation of p‐hydroxytriamterene by platelet phenol sulphotransferase: assay conditions and correlation with metabolism in man.. British Journal of Clinical Pharmacology. 15(2). 211–220. 4 indexed citations
13.
Reiter, Christoph, et al.. (1983). Thermolabile and thermostable human platelet phenol sulfotransferase. Naunyn-Schmiedeberg s Archives of Pharmacology. 324(2). 140–147. 106 indexed citations
14.
Loon, Jon Van, et al.. (1983). A study of the determination of dimethylmercury and methylmercury chloride in air. Spectrochimica Acta Part B Atomic Spectroscopy. 38(10). 1339–1346. 20 indexed citations
15.
Keith, Richard A., et al.. (1983). Thiol methylation pharmacogenetics: Heritability of human erythrocyte thiol methyltransferase activity. Clinical Pharmacology & Therapeutics. 34(4). 521–528. 29 indexed citations
16.
Weinshilboum, R. M. & Jon Van Loon. (1982). Human lymphocyte thiopurine methyltransferase pharmacogenetics. 31(2).
17.
Radziuk, Bernard & Jon Van Loon. (1976). Atomic absorption spectroscopy as a detector for the gas chromatographic study of volatile selenium alkanes from Astragalus racemosus. The Science of The Total Environment. 6(3). 251–257. 17 indexed citations
18.
Loon, Jon Van. (1965). Titrimetric determination of the iron(II) oxide content of silicates using potassium iodate. Talanta. 12(6). 599–603. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026